Skip to content
OpenCapital
Get started

Revvity RVTY Diagnostics — Foreign currency translation

Other segment segments

Life Sciences
-$24.95M-174%

Similar metrics at other companies

Agilent Technologies logo
ADiagnostics and Genomics — Foreign currency translation impact
-$3.75M-1,600%
GE HealthCare Technologies logo
GEHCPDx — Foreign currency exchange and other
-$3M-400%
Agilent Technologies logo
ALife Sciences and Applied Markets — Foreign currency translation impact
$1M0.0%
Teledyne Technologies logo
TDYDigital Imaging — Foreign currency changes and other
-$26.6M—
Viatris logo
VTRSDeveloped Markets Segment — Foreign currency translation
-$62.8M-125%
IQVIA logo
IQVResearch & Development Solutions — Impact of foreign currency fluctuations and other
-$11M-257%

Other financials

Income statement

See full
Revenue$711.1M+7.0%
Gross profit$387.7M+3.2%
Operating income$75.9M+5.1%
Net income$40.7M-3.6%
EPS (diluted)$0.36+2.9%

Balance sheet

See full
Cash & equivalents$861.5M-24.3%
Total debt$3.9B+17.8%
Total equity$7.2B-5.9%
Total assets$12.0B-2.9%

Cash flow

See full
Operating cash flow$115.2M-10.1%
CapEx$19.8M+23.7%
Free cash flow$95.5M-14.9%

Valuation

See full
Market cap$11.16B-22.9%
Enterprise value$14.24B-13.7%
P/E46.5×-4.0×
P/S3.8×-1.4×

Profitability

See full
Gross margin48.5%—
Operating margin12.4%-1.1pp
Net margin8.3%-2.1pp
FCF margin17%-1.9pp

Returns & leverage

See full
Return on equity3.2%-0.5pp
Debt / equity0.5×+0.1×
Current ratio1.7×-1.9×

Where this comes from

Reported directly by Revvity in its filing.

Tagged under the XBRL concept us-gaap:GoodwillForeignCurrencyTranslationGainLoss.

The official record: Revvity’s 10-Q, filed May 12, 2026, on SEC EDGAR. View the filing →

Ask your AI about Revvity's diagnostics — foreign currency translation.

Connect your AI assistant and compare segments, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Revvity's diagnostics — foreign currency translation?
Revvity (RVTY) reported diagnostics — foreign currency translation of -$9.83M in Q1 2026.
How has Revvity's diagnostics — foreign currency translation changed year-over-year?
Revvity's diagnostics — foreign currency translation decreased by 169.0% year-over-year, from $14.24M to -$9.83M.
What does diagnostics — foreign currency translation mean?
The financial impact of changing currency exchange rates on the diagnostics segment's reported results.
How do you interpret diagnostics — foreign currency translation?
A positive value indicates a gain from currency movements, while a negative value indicates a loss, signaling exposure to international market volatility.
How does diagnostics — foreign currency translation compare across companies?
Commonly reported by multinational life science companies as 'Foreign Exchange Impact' or 'FX Translation'.